European Journal of Cancer
Volume 39, Issue 13 , Pages 1835-1841 , September 2003

New non-angiogenesis dependent pathways for tumour growth

  • D. Ribatti

      Affiliations

    • Department of Human Anatomy and Histology, University of Bari Medical School, Piazza Giulio Cesare, 11, Policlinico, 70124, Bari, Italy
    • Corresponding Author InformationCorresponding author. Tel.: +39-080-5478240; fax: +39-080-5478310
    • ,
  • A. Vacca

      Affiliations

    • Department of Biomedical Sciences and Human Oncology, University of Bari Medical School, Bari, Italy
    • ,
  • F. Dammacco

      Affiliations

    • Department of Biomedical Sciences and Human Oncology, University of Bari Medical School, Bari, Italy

Received 8 October 2002 ,Revised 17 January 2003 ,Accepted 12 March 2003.

References 

  1. Ribatti D, Vacca A, Dammacco F. The role of vascular phase in solid tumor growth (a historical review). Neoplasia. 1999;1:293–302
  2. Folkman J. Angiogenesis. In:  Jaffe EA editors. Biology of endothelial cell. Amsterdam: Martinus Nijhoff Publishing; 1984;p. 412–428
  3. Folkman J. Tumor angiogenesis. In:  Mendelshon J,  Howley PM,  Israel MA,  Liotta LA editor. The molecular basis of cancer. Philadelphia: WB Saunders; 1995;p. 206–232
  4. Hanahan D, Folkman J. Patterns and emerging mechanisms of the angiogenic switch during tumorigenesis. Cell. 1996;86:353–364
  5. Hanahan D. Heritable formation of pancreatic beta-cell tumors in transgenic mice expressing recombinant insulin/simian virus 40 oncogene. Nature. 1985;315:115–122
  6. Folkman J, Watson KM, Ingber DE, Hanahan D. Induction of angiogenesis during the transition from hyperplasia to neoplasia. Nature. 1989;339:58–61
  7. Dvorak HF. Vascular permeability factor/vascular endothelial growth factor (a critical cytokine in tumor angiogenesis and a potential target for diagnosis and therapy). J Clin Oncol. 2002;20:4368–4380
  8. Crowther M, Brown NJ, Bishop ET, Lewis CE. Microenvironmental influence on macrophage regulation of angiogenesis in wounds and malignant tumors. J Leukoc Biol. 2001;70:478–490
  9. Maragoudakis ME. Angiogenesis in health and disease. Gen Pharmacol. 2002;35:225–226
  10. Eberhard A, Kahlert S, Goede V, Hemmerlein B, Plate KH, Augustin HG. Heterogeneity of angiogenesis and blood vessel maturation in human tumors (implications for antiangiogenic tumor therapies). Cancer Res. 2002;60:1388–1393
  11. Turner HE, Nagy Z, Gatter KC, Esiri MM, Harris AL, Wass JA. Angiogenesis in pituitary adenomas and in the normal pituitary gland. J Clin Endocrinol Metab. 2000;85:1159–1162
  12. Sterinberg F, Rohrborn HJ, Otto T, Scheufler KM, Streffer C. NIR reflection measurements of hemoglobin and cytochrome da3 in healthy tissue and tumors. Correlation to oxygen consuption: preclinical and clinical data. Adv Exp Med Biol. 1997;428:69–77
  13. Graeber TG, Osmanian C, Jacks T, et al.  Hypoxia-mediated selection of cells with diminished apoptotic potential in solid tumours. Nature. 1996;379:88–91
  14. Pezzella F, Pastorino U, Tagliabue E, et al.  Non-sall-lung carcinoma tumor growth without morphological evidence of neo-angiogenesis. Am J Pathol. 1997;151:1417–1423
  15. Holash J, Maisonpierre PC, Compton D, et al.  Vessel cooption, regression and growth in tumors mediated by angiopoietins and VEGF. Science. 1999;284:1994–1998
  16. Yancopoulos GD, Davis S, Gale NW, Rudge JS, Wiegand SJ, Holash J. Vascular specific growth factors and blood vessels formation. Nature. 2000;407:242–248
  17. Maniotis AJ, Folberg R, Hess A, et al.  Vascular channel formation by human melanoma cells in vivo and in vitro (vasculogenic mimicry). Am J Pathol. 1999;155:739–752
  18. Pastorino U, Andreola S, Tagliabue E, et al.  Imunohistochemical markers in stage I lung cancer (relevance to prognosis). J Clin Oncol. 1997;15:2858–2865
  19. Wesseling P, Van Der Laak JA, De Leeuw H, Ruiter DJ, Burger PC. Quantitative immunohistological analysis of the microvasculature in untreated human glioblastoma multiforme. Computer-assisted image analysis of whole tumor sections. J Neurosurg. 1994;81:902–9009
  20. Pezzella F. Evidence for novel non-angiogenic pathway in breast-cancer metastasis. Breast Cancer Progression Working Parthy. Lancet. 2000;355:1787–1788
  21. Guidi AJ, Berry DA, Broadwater G, et al.  Association of angiogenesis in lymph node metastases with outcome of breast cancer. J Natl Cancer Inst. 2000;92:486–492
  22. Naresh NK, Nerurkar AY, Borges AM. Angiogenesis is a redundant for tumour growth in lymph node metastases. Histopathology. 2001;38:466–470
  23. Zagzag D, Hooper A, Friedlander DR, et al.  In situ expression of angiopoietins in astrocytomas identifies angiopoietin-2 as an early marker of tumor angiogenesis. Exp Neurol. 1999;159:391–400
  24. Holash J, Wiegand SJ, Yancopoulos GF. New model of tumor angiogenesis (dynamic balance between vessel regression and growth mediated by angiopoietins and VEGF). Oncogene. 1999;18:5356–5362
  25. Vajkoczy P, Farhadi M, Gaumann A, et al.  Microtumor growth initiates angiogenic sprouting with simulatenous expression of VEGF, VEGF receptor-2, and angiopoietin-2. J Clin Invest. 2002;109:777–785
  26. Seftor REB, Seftor EA, Koshikawa N, et al.  Cooperative interactions of laminin 5 gamma-2 chain, matrix metalloproteinase-2, and membrane type-1-matrix/metalloproteinase are required for mimicry of embryonic vasculogenesis by aggressive melanoma. Cancer Res. 2001;61:6322–6327
  27. McDonald DM, Munn L, Jain RK. Vasculogenic mimicry (how convincing, how novel, and how significant). Am J Pathol. 2000;156:383–388
  28. Jensen OA. The Knapp-Ronne type of malignant melanoma of the choroid (a haemangioma-like melanoma with a typical clinical picture. So-called “preretinal malignant choroid melanoma”). Acta Ophthalmol. 1976;54:41–54
  29. Duke-Elder S, Perkins ES. Cysts and tumors of the uveal tract. In:  Duke-Elder S editors. System of ophthalmology. St. Louis, CV: Mosby Company; 1996;p. 754–937
  30. Francois J, Neetens A. Physico-anatomical studies of spontaneous and experimental intraocular new growths (vascular supply). Bibl Anat. 1967;9:403–411
  31. Warren BA. The vascular morphology of tumors. In:  Patherson HI editors. Tumor blood circulation: angiogenesis, vascular morphology and blood flow of experimental and human tumors. Boca Raton: CRC Press Inc; 1979;p. 1–48
  32. Prause JU, Jensen OA. Scanning electron microscopy of frozen-cracked, dry-cracked and enzyme-digested tissue of human malignant choriodal melanomas. Albrecht Von Gralfes Arch Klin Exp Ophthalmol. 1980;212:217–225
  33. Hammersen F, Endrich B, Messmer K, The fine structure of tumor blood vessels I. Partecipation of non-endothelial cells in tumor angiogenesis. Int J Microcirc Clin Exp. 1985;4:31–43
  34. Baron JA, Monzon F, Galaria N, Murphy GF. Angiomatoid melanoma (a novel pattern of differentiation in invasive periocular desmoplastic malignant melanoma). Hum Pathol. 2000;31:1520–1522
  35. Sood AK, Seftor EA, Fletcher MS, et al.  Molecular determinants of ovarian cancer plasticity. Am J Pathol. 2001;158:1279–1288
  36. Shirakawa K, Shibuya M, Heike Y, et al.  Tumor-infiltrating endothelial cells and endothelial precursor cells in inflammatory breast cancer. Int J Cancer. 2002;99:344–351
  37. Chang YS, di Tomaso E, Mc Donald DM, Jones R, Jain RK, Munn LL. Mosaic blood vessels in tumors (frequency of cancer cells in contact with flowing blood). Proc Natl Acad Sci USA. 2000;97:14608–14613
  38. Asahara T, Takahashi T, Masuda H, et al.  VEGF contributes to postnatal neovascularization by mobilizing bone-marrow derived endothelial progenitor cells. EMBO J. 1999;18:3964–3972
  39. Hattori K, Dias S, Heissig B, et al.  Vascular endothelial growth factor and angiopoietin-1 stimulate postnatal hematopoiesis by recruitment of vasculogenic and hematopoietic stem cells. J Exp Med. 2000;193:1005–1014
  40. Takahashi T, Kalka C, Masuda H, et al.  Ischemia- and cytokine-induced mobilization of bone marrow-derived endothelial progenitor cells for neovascularization. Nature Med. 1999;5:434–438
  41. Lyden D, Hattori K, Dias S, et al.  Impaired recruitment of bone-marrow-derived endothelial and hematopoietic precursor cells blocks tumor angiogenesis and growth. Nature Med. 2001;7:1194–1201
  42. Reyes M, Dudek A, Jahagirdar B, Koodie L, Marker PH, Verfaillie CM. Origin of endothelial progenitors in human postnatal bone marrow. J Clin Invest. 2002;109:337–346
  43. Clarijs R, Ruiter DJ, De Wall RM. Lymphangiogenesis in malignant tumours (does it occur?). J Pathol. 2001;193:143–146
  44. Pepper MS. Lymphangiogenesis and tumor metastasis: myth or reality?. Clin Cancer Res. 2001;7:462–468
  45. Makinen T, Veikkola T, Mustjoki S, et al.  Isolated lymphatic endothelial cells transduce growth, survival and migratory signals via the VEGFC/D receptor VEGFR-3. EMBO J. 2001;20:4762–4773
  46. Stacker SA, Baldwin ME, Achen MG. The role of tumor lymphangiogenesis in metastatic spread. FASEB J. 2002;16:922–934
  47. Shirakawa K, Kobayashi H, Heike Y, et al.  Hemodynamics in vasculogenic mimicry and angiogenesis of inflammatory breast cancer xenograft. Cancer Res. 2002;62:560–566
  48. Scappaticci FA. Mechanisms and future directions for angiogenesis-based cancer therapies. J Clin Oncol. 2002;20:3906–3927
  49. Kerbel RS. Inhibition of tumor angiogenesis as a strategy to circumvent acquired resistance to anti-cancer therapeutic agents. BioEssay. 1991;13:31–36
  50. Klement G, Baruchel S, Rak J, et al.  Continuous low-dose therapy with vinblastine and VEGF receptor-2 antibody induces sustained tumor regression without overt toxicity. J Clin Invest. 2000;105:R15–R24
  51. Davidoff AM, NG CYC, Brown, P, et al. Bone marrow-derived cells contribute to tumor neovasculature and, when modified to express an angiogenesis inhibitor, can restrict tumor growth in mice. Clin Cancer Res 2001, 7, 2870-2879.
  52. He Y, Kozaki K, Karpanen T, et al.  Suppression of tumor lymphangiogenesis and lymph node metastasis by blocking vascular endothelial growth factor receptor 3 signaling. J Natl Cancer Inst. 2002;94:819–825

PII: S0959-8049(03)00267-3

doi: 10.1016/S0959-8049(03)00267-3

European Journal of Cancer
Volume 39, Issue 13 , Pages 1835-1841 , September 2003

Article Tools